430 related articles for article (PubMed ID: 33818412)
1. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
Suryana KD; Simadibrata M; Renaldi K
Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
[TBL] [Abstract][Full Text] [Related]
2. Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection.
Zhang H; Li HB; Lyu JR; Lei XM; Li W; Wu G; Lyu J; Dai ZM
Int J Infect Dis; 2020 Jul; 96():19-24. PubMed ID: 32311451
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.
Galanopoulos M; Gkeros F; Doukatas A; Karianakis G; Pontas C; Tsoukalas N; Viazis N; Liatsos C; Mantzaris GJ
World J Gastroenterol; 2020 Aug; 26(31):4579-4588. PubMed ID: 32884218
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
7. Implications of SARS-CoV-2 infection for neurogastroenterology.
Marasco G; Lenti MV; Cremon C; Barbaro MR; Stanghellini V; Di Sabatino A; Barbara G
Neurogastroenterol Motil; 2021 Mar; 33(3):e14104. PubMed ID: 33591607
[TBL] [Abstract][Full Text] [Related]
8. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea.
Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ
Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19.
Patel KP; Patel PA; Vunnam RR; Hewlett AT; Jain R; Jing R; Vunnam SR
J Clin Virol; 2020 Jul; 128():104386. PubMed ID: 32388469
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management.
Deidda S; Tora L; Firinu D; Del Giacco S; Campagna M; Meloni F; Orrù G; Chessa L; Carta MG; Melis A; Spolverato G; Littera R; Perra A; Onali S; Zorcolo L; Restivo A
Expert Rev Gastroenterol Hepatol; 2021 Jan; 15(1):41-50. PubMed ID: 32955375
[TBL] [Abstract][Full Text] [Related]
11. The Thrilling Journey of SARS-CoV-2 into the Intestine: From Pathogenesis to Future Clinical Implications.
Scaldaferri F; Ianiro G; Privitera G; Lopetuso LR; Vetrone LM; Petito V; Pugliese D; Neri M; Cammarota G; Ringel Y; Costamagna G; Gasbarrini A; Boskoski I; Armuzzi A
Inflamm Bowel Dis; 2020 Aug; 26(9):1306-1314. PubMed ID: 32720978
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks EF; Bhatt AS
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
[TBL] [Abstract][Full Text] [Related]
13. An overview of the gut side of the SARS-CoV-2 infection.
Barbosa da Luz B; de Oliveira NMT; França Dos Santos IW; Paza LZ; Braga LLVM; Platner FDS; Werner MFP; Fernandes ES; Maria-Ferreira D
Intest Res; 2021 Oct; 19(4):379-385. PubMed ID: 33142370
[TBL] [Abstract][Full Text] [Related]
14. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings.
Sahu T; Mehta A; Ratre YK; Jaiswal A; Vishvakarma NK; Bhaskar LVKS; Verma HK
World J Gastroenterol; 2021 Feb; 27(6):449-469. PubMed ID: 33642821
[TBL] [Abstract][Full Text] [Related]
16. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19.
Levy E; Stintzi A; Cohen A; Desjardins Y; Marette A; Spahis S
Am J Physiol Gastrointest Liver Physiol; 2021 Aug; 321(2):G99-G112. PubMed ID: 34009033
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms.
Zhong P; Xu J; Yang D; Shen Y; Wang L; Feng Y; Du C; Song Y; Wu C; Hu X; Sun Y
Signal Transduct Target Ther; 2020 Nov; 5(1):256. PubMed ID: 33139693
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated diarrhea.
Megyeri K; Dernovics Á; Al-Luhaibi ZII; Rosztóczy A
World J Gastroenterol; 2021 Jun; 27(23):3208-3222. PubMed ID: 34163106
[TBL] [Abstract][Full Text] [Related]
19. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.
Lei HY; Ding YH; Nie K; Dong YM; Xu JH; Yang ML; Liu MQ; Wei L; Nasser MI; Xu LY; Zhu P; Zhao MY
Biomed Pharmacother; 2021 Jan; 133():111064. PubMed ID: 33378966
[TBL] [Abstract][Full Text] [Related]
20. Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract.
Galanopoulos M; Doukatas A; Gazouli M
World J Gastroenterol; 2020 Nov; 26(41):6335-6345. PubMed ID: 33244196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
